Bio Molecular Systems

Executive Summary

Bio Molecular Systems (BMS) is an Australian med-tech company specializing in precision robotics and real-time PCR instrumentation for clinical and research laboratories. Its flagship products—the Myra liquid-handling platform and the Mic magnetic-induction qPCR cycler—are integrated with AI-driven software to automate workflows and manage data. BMS targets low- to mid-throughput labs seeking affordable, compact automation solutions, differentiating itself from larger players like Tecan or Thermo Fisher through its innovative induction heating technology and user-friendly software. The company serves a growing segment of decentralized diagnostic testing and academic research, particularly in Asia-Pacific and Europe.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for Mic qPCR cycler in the US60% success
• Q4 2026Strategic partnership with a global diagnostics distributor40% success
• Q1 2027Launch of next-gen Myra X1 liquid handler with expanded capacity70% success